SCFAs are capable of traversing the blood-brain barrier to modulate central nervous system (CNS) activity, while dysregulation of microbiota-derived neurotransmitters, such as gamma-aminobutyric acid (GABA) and dopamine, is implicated in CNS disorders, including schizophrenia 35
Wegovy (semaglutide) is a once-a-week injection thats approved by the Food and Drug Administration (FDA) to: Reduce excess body weight and maintain weight reduction in: Adults with a body mass index (BMI) of 30 or higher Adults with a BMI of 27 or higher who also have weight-related medical problems, such as high cholesterol or high blood pressure Adolescents ages 1217 who are at or above the 95th percentile on sex- and age-specific growth charts Reduce the risk of major adverse cardiovascular events in adults with established cardiovascular disease and a BMI of 27 or higher Wegovy belongs to a family of drugs called glucagon-like peptide-1 (GLP-1) receptor agonists)
Standard medical dosing for confirmed deficiency typically involves an initial loading phase followed by maintenance
From an electrolyte perspective, alcohol makes everything harder
Orphanet J Rare Dis 15:59
The study suggests that Medicaid coverage is a smart investment in public health
.png)
